Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status

Show other versions (1)
Bibliographic Details
Main Authors: Nagla Abdel Karim, Salma Musaad, Ahmad Zarzour, Sadan, Patil, Abdul Rahman Jazieh
Format: Article
Language:English
Published: SAGE Publishing 2014-11-01
Series:Clinical Medicine Insights: Oncology
Online Access:http://www.la-press.com/phase-ii-clinical-trial-of-gefitinib-for-the-treatment-of-chemonave-pa-article-a4519
id doaj-0d341ed739704110867e5757f74f68cf
record_format Article
spelling doaj-0d341ed739704110867e5757f74f68cf2020-11-25T03:25:09ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492014-11-01201481211284519Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance StatusNagla Abdel KarimSalma MusaadAhmad ZarzourSadanPatilAbdul Rahman Jaziehhttp://www.la-press.com/phase-ii-clinical-trial-of-gefitinib-for-the-treatment-of-chemonave-pa-article-a4519
collection DOAJ
language English
format Article
sources DOAJ
author Nagla Abdel Karim
Salma Musaad
Ahmad Zarzour
Sadan
Patil
Abdul Rahman Jazieh
spellingShingle Nagla Abdel Karim
Salma Musaad
Ahmad Zarzour
Sadan
Patil
Abdul Rahman Jazieh
Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
Clinical Medicine Insights: Oncology
author_facet Nagla Abdel Karim
Salma Musaad
Ahmad Zarzour
Sadan
Patil
Abdul Rahman Jazieh
author_sort Nagla Abdel Karim
title Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
title_short Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
title_full Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
title_fullStr Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
title_full_unstemmed Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
title_sort phase ii clinical trial of gefitinib for the treatment of chemonaïve patients with advanced non-small cell lung cancer with poor performance status
publisher SAGE Publishing
series Clinical Medicine Insights: Oncology
issn 1179-5549
publishDate 2014-11-01
url http://www.la-press.com/phase-ii-clinical-trial-of-gefitinib-for-the-treatment-of-chemonave-pa-article-a4519
work_keys_str_mv AT naglaabdelkarim phaseiiclinicaltrialofgefitinibforthetreatmentofchemonaivepatientswithadvancednonsmallcelllungcancerwithpoorperformancestatus
AT salmamusaad phaseiiclinicaltrialofgefitinibforthetreatmentofchemonaivepatientswithadvancednonsmallcelllungcancerwithpoorperformancestatus
AT ahmadzarzour phaseiiclinicaltrialofgefitinibforthetreatmentofchemonaivepatientswithadvancednonsmallcelllungcancerwithpoorperformancestatus
AT sadan phaseiiclinicaltrialofgefitinibforthetreatmentofchemonaivepatientswithadvancednonsmallcelllungcancerwithpoorperformancestatus
AT patil phaseiiclinicaltrialofgefitinibforthetreatmentofchemonaivepatientswithadvancednonsmallcelllungcancerwithpoorperformancestatus
AT abdulrahmanjazieh phaseiiclinicaltrialofgefitinibforthetreatmentofchemonaivepatientswithadvancednonsmallcelllungcancerwithpoorperformancestatus
_version_ 1724598749961912320

Similar Items